1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kohda, D. Terasawa, H. Hatanaka, H. Inagaki, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 2 1029 1040 10.1016/S0969-2126(94)00106-5 7881903 Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2. 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6785.427 GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 1 man polymer no no GSTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNR GSTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample GRB2 9606 Homo sapiens pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-08-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1994-06-13 REL 1 BRUNGER refinement X-PLOR GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A THR 3 n 3 THR 3 A TYR 4 n 4 TYR 4 A VAL 5 n 5 VAL 5 A GLN 6 n 6 GLN 6 A ALA 7 n 7 ALA 7 A LEU 8 n 8 LEU 8 A PHE 9 n 9 PHE 9 A ASP 10 n 10 ASP 10 A PHE 11 n 11 PHE 11 A ASP 12 n 12 ASP 12 A PRO 13 n 13 PRO 13 A GLN 14 n 14 GLN 14 A GLU 15 n 15 GLU 15 A ASP 16 n 16 ASP 16 A GLY 17 n 17 GLY 17 A GLU 18 n 18 GLU 18 A LEU 19 n 19 LEU 19 A GLY 20 n 20 GLY 20 A PHE 21 n 21 PHE 21 A ARG 22 n 22 ARG 22 A ARG 23 n 23 ARG 23 A GLY 24 n 24 GLY 24 A ASP 25 n 25 ASP 25 A PHE 26 n 26 PHE 26 A ILE 27 n 27 ILE 27 A HIS 28 n 28 HIS 28 A VAL 29 n 29 VAL 29 A MET 30 n 30 MET 30 A ASP 31 n 31 ASP 31 A ASN 32 n 32 ASN 32 A SER 33 n 33 SER 33 A ASP 34 n 34 ASP 34 A PRO 35 n 35 PRO 35 A ASN 36 n 36 ASN 36 A TRP 37 n 37 TRP 37 A TRP 38 n 38 TRP 38 A LYS 39 n 39 LYS 39 A GLY 40 n 40 GLY 40 A ALA 41 n 41 ALA 41 A CYS 42 n 42 CYS 42 A HIS 43 n 43 HIS 43 A GLY 44 n 44 GLY 44 A GLN 45 n 45 GLN 45 A THR 46 n 46 THR 46 A GLY 47 n 47 GLY 47 A MET 48 n 48 MET 48 A PHE 49 n 49 PHE 49 A PRO 50 n 50 PRO 50 A ARG 51 n 51 ARG 51 A ASN 52 n 52 ASN 52 A TYR 53 n 53 TYR 53 A VAL 54 n 54 VAL 54 A THR 55 n 55 THR 55 A PRO 56 n 56 PRO 56 A VAL 57 n 57 VAL 57 A ASN 58 n 58 ASN 58 A ARG 59 n 59 ARG 59 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 27 A N ILE 27 A O VAL 5 A O VAL 5 A N GLN 6 A N GLN 6 A O THR 55 A O THR 55 A N PHE 11 A N PHE 11 A O PHE 21 A O PHE 21 A O ASP 31 A O ASP 31 A N LYS 39 A N LYS 39 A O TRP 38 A O TRP 38 A N PHE 49 A N PHE 49 1 A ARG 22 0.197 SIDE CHAIN 1 A ARG 23 0.259 SIDE CHAIN 1 A ARG 51 0.319 SIDE CHAIN 1 A ARG 59 0.179 SIDE CHAIN 1 -6.21 1.00 110.10 103.89 A A A CG CD1 NE1 TRP TRP TRP 37 37 37 N 1 5.93 0.90 109.00 114.93 A A A CD1 NE1 CE2 TRP TRP TRP 37 37 37 N 1 8.13 1.10 130.40 138.53 A A A NE1 CE2 CZ2 TRP TRP TRP 37 37 37 N 1 -6.20 1.00 107.30 101.10 A A A NE1 CE2 CD2 TRP TRP TRP 37 37 37 N 1 -6.92 1.00 110.10 103.18 A A A CG CD1 NE1 TRP TRP TRP 38 38 38 N 1 6.42 0.90 109.00 115.42 A A A CD1 NE1 CE2 TRP TRP TRP 38 38 38 N 1 9.80 1.10 130.40 140.20 A A A NE1 CE2 CZ2 TRP TRP TRP 38 38 38 N 1 -6.84 1.00 107.30 100.46 A A A NE1 CE2 CD2 TRP TRP TRP 38 38 38 N 1 -6.28 0.90 133.90 127.62 A A A CG CD2 CE3 TRP TRP TRP 38 38 38 N 1 A A CG ND1 HIS HIS 28 28 -0.100 0.015 1.369 1.269 N 1 A A CG CD2 TRP TRP 38 38 -0.106 0.017 1.432 1.326 N 1 A A CG ND1 HIS HIS 43 43 -0.102 0.015 1.369 1.267 N 1 A ALA 7 -24.38 109.76 1 A PRO 13 -43.63 161.04 1 A GLN 14 -155.00 -5.66 1 A ARG 23 -14.98 136.03 1 A VAL 29 -64.03 88.95 1 A ASP 31 -171.78 97.74 1 A ASN 32 -58.42 109.47 1 A SER 33 -98.20 -75.48 1 A CYS 42 -169.95 -87.18 1 A HIS 43 -63.74 72.59 model building X-PLOR refinement X-PLOR phasing X-PLOR GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 (GRB2) (C-TERMINAL SH3 DOMAIN) (NMR, MINIMIZED MEAN STRUCTURE) SOLUTION STRUCTURE AND LIGAND-BINDING SITE OF THE C-TERMINAL SH3 DOMAIN OF GRB2 1 Y N A ARG 51 A ARG 51 HELX_P 3/10 HELIX A TYR 53 A TYR 53 5 GH 3 ADAPTOR PROTEIN CONTAINING SH2 AND SH3 ADAPTOR PROTEIN CONTAINING SH2 AND SH3 GRB2_HUMAN UNP 1 1 P62993 MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPWFFGKIPRAKAEEMLSKQRHD GAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTY VQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV 159 215 1GFC 3 59 P62993 A 1 3 59 3 2 3 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ASP 25 A ASP 25 A VAL 29 A VAL 29 A TYR 4 A TYR 4 A ALA 7 A ALA 7 A VAL 54 A VAL 54 A PRO 56 A PRO 56 A PHE 9 A PHE 9 A ASP 12 A ASP 12 A GLY 20 A GLY 20 A ARG 22 A ARG 22 A ASP 31 A ASP 31 A ASN 32 A ASN 32 A TRP 37 A TRP 37 A CYS 42 A CYS 42 A GLN 45 A GLN 45 A PRO 50 A PRO 50 1 P 1